Edward Nirenberg on Nostr: ACIP is concerned about the "immunologic vaccine effectiveness" term being used ...
ACIP is concerned about the "immunologic vaccine effectiveness" term being used because it sounds like it applies at the individual level, whereas vaccine effectiveness is a population-based metric. GSK says they have to call it this because you cannot feasibly measure efficacy.
Published at
2024-06-28 14:03:38Event JSON
{
"id": "e09a02ec56d17193f8c5d9cfa0a30baad1857f2ea3bdfc84fbe438c10e221276",
"pubkey": "c67b38e4c5023e985f04ae7ab6a6669cf463220e1b9ed54b897d1957004603a4",
"created_at": 1719583418,
"kind": 1,
"tags": [
[
"e",
"7f7617e4486023f402ab1352dd185b7b9dfd117e4a0e7c4148b7f437f88c9ae5",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://med-mastodon.com/users/enirenberg/statuses/112694618909344173",
"activitypub"
]
],
"content": "ACIP is concerned about the \"immunologic vaccine effectiveness\" term being used because it sounds like it applies at the individual level, whereas vaccine effectiveness is a population-based metric. GSK says they have to call it this because you cannot feasibly measure efficacy.",
"sig": "024a0d2cf95cb0c1df742bc55dcf603439321a977f3b028db4b99f20c499f4d662e330ee85790b60d7000e47c4f50ec51ce5224f5e19953c330ce1d73b67f389"
}
